Proteomic analyses in diverse populations improved risk prediction and identified new drug targets for type 2 diabetes
Pang Yao(Peking University), Zhengming Chen(Population Council), Mohsen Mazidi(King's College London), Ling Yang(Tongji University), Andri Iona(University of Oxford), Dianjianyi Sun(Peking University), Fiona Bragg(University of Oxford), Canqing Yu(Peking University), Dan Schmidt(University of Oxford), Robert Clarke(Nuffield Health), Alfred Pozarickij(University of Oxford), Junxi Liu, Hannah Fry(University of Oxford), Christiana Kartsonaki(University of Oxford), Iona Y. Millwood(University of Oxford), Robin Walters(Northeastern University), Derrick Bennett(American Council on Education), Saredo Said(Novo Nordisk (Finland)), Jun Lv(Shanghai Jiao Tong University), Neil Wright(University of Oxford), Huaidong Du(University of Oxford), Yiping Chen(Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University), Bowen Liu(Shanghai Public Health Clinical Center), Liming Li(Peking University), Michael Hill(University of Ottawa), Kuang Lin(University of Oxford), Daniel Avery(University of Oxford)
Cited by 0
Related Papers
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
|The Lancet|2012|9k
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
|The Lancet|2012|8.4k
Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010
|The Lancet|2013|3.9k